Li D - Search Results

1

The competitive binding between inhibitors and substrates of HCV NS3/4A protease: a general mechanism of drug resistance.

Guan Y, Sun H, Li Y, Pan P, Li D, Hou T. Guan Y, et al. Among authors: li d, li y. Antiviral Res. 2014 Mar;103:60-70. doi: 10.1016/j.antiviral.2014.01.010. Epub 2014 Jan 23. Antiviral Res. 2014. PMID: 24462696

2

Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.

Pan P, Li L, Li Y, Li D, Hou T. Pan P, et al. Among authors: li d, li y, li l. Antiviral Res. 2013 Nov;100(2):356-64. doi: 10.1016/j.antiviral.2013.09.006. Epub 2013 Sep 19. Antiviral Res. 2013. PMID: 24055835

3

Exploring resistance mechanisms of HCV NS3/4A protease mutations to MK5172: insight from molecular dynamics simulations and free energy calculations.

Guan Y, Sun H, Pan P, Li Y, Li D, Hou T. Guan Y, et al. Among authors: li d, li y. Mol Biosyst. 2015 Sep;11(9):2568-78. doi: 10.1039/c5mb00394f. Mol Biosyst. 2015. PMID: 26219385

4

Theoretical study on the interaction of pyrrolopyrimidine derivatives as LIMK2 inhibitors: insight into structure-based inhibitor design.

Shen M, Zhou S, Li Y, Li D, Hou T. Shen M, et al. Among authors: li d, li y. Mol Biosyst. 2013 Oct;9(10):2435-46. doi: 10.1039/c3mb70168a. Mol Biosyst. 2013. PMID: 23881296

5

Insight into crizotinib resistance mechanisms caused by three mutations in ALK tyrosine kinase using free energy calculation approaches.

Sun H, Li Y, Li D, Hou T. Sun H, et al. Among authors: li d, li y. J Chem Inf Model. 2013 Sep 23;53(9):2376-89. doi: 10.1021/ci400188q. Epub 2013 Aug 29. J Chem Inf Model. 2013. PMID: 23952683

6

Development and evaluation of an integrated virtual screening strategy by combining molecular docking and pharmacophore searching based on multiple protein structures.

Tian S, Sun H, Li Y, Pan P, Li D, Hou T. Tian S, et al. Among authors: li d, li y. J Chem Inf Model. 2013 Oct 28;53(10):2743-56. doi: 10.1021/ci400382r. Epub 2013 Sep 24. J Chem Inf Model. 2013. PMID: 24010823

7

Advances in the development of Rho-associated protein kinase (ROCK) inhibitors.

Pan P, Shen M, Yu H, Li Y, Li D, Hou T. Pan P, et al. Among authors: li d, li y. Drug Discov Today. 2013 Dec;18(23-24):1323-33. doi: 10.1016/j.drudis.2013.09.010. Epub 2013 Sep 25. Drug Discov Today. 2013. PMID: 24076262 Review.

8

Theoretical studies on beta and delta isoform-specific binding mechanisms of phosphoinositide 3-kinase inhibitors.

Zhu J, Pan P, Li Y, Wang M, Li D, Cao B, Mao X, Hou T. Zhu J, et al. Among authors: li d, li y. Mol Biosyst. 2014 Mar 4;10(3):454-66. doi: 10.1039/c3mb70314b. Epub 2013 Dec 16. Mol Biosyst. 2014. PMID: 24336903

9

ADMET evaluation in drug discovery. 13. Development of in silico prediction models for P-glycoprotein substrates.

Li D, Chen L, Li Y, Tian S, Sun H, Hou T. Li D, et al. Among authors: li y. Mol Pharm. 2014 Mar 3;11(3):716-26. doi: 10.1021/mp400450m. Epub 2014 Feb 18. Mol Pharm. 2014. PMID: 24499501

10

Exploring the prominent performance of CX-4945 derivatives as protein kinase CK2 inhibitors by a combined computational study.

Wang X, Pan P, Li Y, Li D, Hou T. Wang X, et al. Among authors: li d, li y. Mol Biosyst. 2014 May;10(5):1196-210. doi: 10.1039/c4mb00013g. Mol Biosyst. 2014. PMID: 24647611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51,792 results

Search Page

Filters